Skip to main content

Advertisement

Figure 1 | BMC Neurology

Figure 1

From: Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis

Figure 1

Lesion numbers at Weeks 24 and 48. A) New or newly-enlarging T2 lesions aBased on negative binomial regression analysis, adjusted baseline T2 lesion number. The data for 48 weeks has been published previously [10]. CI = confidence interval. B) New T1 hypointense lesions compared to baseline bBased on mean number of new lesions only and p value based on multiple logit regression, adjusted for baseline number of T1 lesions. The data for 48 weeks has been published previously [10]. SE = standard error. C) Gd+ lesions cBased on mean number of lesions only and p value based on multiple logit regression, adjusted for baseline number of Gd+ lesions. Gd+ = gadolinium-enhancing; SE = standard error.

Back to article page